ORPHAZYME TO PRESENT AT REDEYE LIFE SCIENCE DAY

Copenhagen, November 20, 2018 – Orphazyme A/S, a biopharmaceutical company dedicated to developing treatments for patients living with rare diseases, today announced that Anders Hinsby, Chief Executive Officer at Orphazyme, will be presenting at the Redeye Life Science Day in Stockholm, Sweden, on November 21, 2018.